Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-FR Version v2-FR
Language French French
Date Updated 2020-01-10 2020-01-10
Drug Identification Number 00636576 00636576
Brand name LIORESAL D.S. TAB 20MG LIORESAL D.S. TAB 20MG
Common or Proper name LIORESAL D.S. 20MG CT 100'S LIORESAL D.S. 20MG CT 100'S
Company Name NOVARTIS PHARMACEUTICALS CANADA INC NOVARTIS PHARMACEUTICALS CANADA INC
Ingredients BACLOFEN BACLOFEN
Strength(s) 20MG 20MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100'S 100'S
ATC code M03BX M03BX
ATC description MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2020-01-31 2020-01-31
Actual discontinuation date
Remaining supply date 2020-01-31 2020-01-31
Discontinuation status To be discontinued To be discontinued
Discontinuation decision reversal no no
Information on remaining supply
Company comments
Health Canada comments